Form 8-K - Current report:
SEC Accession No. 0001213900-25-041531
Filing Date
2025-05-09
Accepted
2025-05-09 16:15:27
Documents
15
Period of Report
2025-05-08
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0241236-8k_bespoke.htm   iXBRL 8-K 26968
2 LETTER FROM ASSURANCE DIMENSIONS ADDRESSED TO THE SECURITIES AND EXCHANGE COMMIS ea0241236ex16-1_bespoke.htm EX-16.1 7059
3 GRAPHIC image_001.jpg GRAPHIC 24170
  Complete submission text file 0001213900-25-041531.txt   239234

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bspk-20250508.xsd EX-101.SCH 3035
5 XBRL LABEL FILE bspk-20250508_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE bspk-20250508_pre.xml EX-101.PRE 22372
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0241236-8k_bespoke_htm.xml XML 3345
Mailing Address 12001 E. 33RD ST- UNIT O AURORA CO 80010
Business Address 12001 E. 33RD ST- UNIT O AURORA CO 80010 720-949-1143
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

EIN.: 204743354 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52759 | Film No.: 25930617
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)